JP6703835B2 -
Amusement machine
- Google Patents
Amusement machine
Download PDF
Info
Publication number
JP6703835B2
JP6703835B2
JP2016000100A
JP2016000100A
JP6703835B2
JP 6703835 B2
JP6703835 B2
JP 6703835B2
JP 2016000100 A
JP2016000100 A
JP 2016000100A
JP 2016000100 A
JP2016000100 A
JP 2016000100A
JP 6703835 B2
JP6703835 B2
JP 6703835B2
Authority
JP
Japan
Prior art keywords
lottery table
winning combination
stop
lottery
internal winning
Prior art date
2016-01-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2016000100A
Other languages
Japanese (ja )
Other versions
JP2017121268A
(en
Inventor
慎介 榎戸
慎介 榎戸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universal Entertainment Corp
Original Assignee
Universal Entertainment Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
2016-01-04
Filing date
2016-01-04
Publication date
2020-06-03
2016-01-04
Application filed by Universal Entertainment Corp
filed
Critical
Universal Entertainment Corp
2016-01-04
Priority to JP2016000100A
priority
Critical
patent/JP6703835B2/en
2017-07-13
Publication of JP2017121268A
publication
Critical
patent/JP2017121268A/en
2020-06-03
Application granted
granted
Critical
2020-06-03
Publication of JP6703835B2
publication
Critical
patent/JP6703835B2/en
Status
Expired - Fee Related
legal-status
Critical
Current
2036-01-04
Anticipated expiration
legal-status
Critical
Links
230000000694
effects
Effects
0.000
claims
description
168
238000003860
storage
Methods
0.000
claims
description
125
238000000034
method
Methods
0.000
description
936
230000008569
process
Effects
0.000
description
892
238000012545
processing
Methods
0.000
description
794
230000007704
transition
Effects
0.000
description
289
238000009165
androgen replacement therapy
Methods
0.000
description
284
238000011950
automated reagin test
Methods
0.000
description
284
238000006243
chemical reaction
Methods
0.000
description
196
230000008859
change
Effects
0.000
description
131
238000010586
diagram
Methods
0.000
description
115
238000002360
preparation method
Methods
0.000
description
108
238000003825
pressing
Methods
0.000
description
101
238000012546
transfer
Methods
0.000
description
58
238000009448
modified atmosphere packaging
Methods
0.000
description
43
230000004913
activation
Effects
0.000
description
31
239000004973
liquid crystal related substance
Substances
0.000
description
30
PZTQVMXMKVTIRC-UHFFFAOYSA-L
chembl2028348
Chemical compound
[Ca+2].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12
PZTQVMXMKVTIRC-UHFFFAOYSA-L
0.000
description
29
238000012423
maintenance
Methods
0.000
description
25
238000001514
detection method
Methods
0.000
description
24
230000006870
function
Effects
0.000
description
23
210000003128
head
Anatomy
0.000
description
20
238000003780
insertion
Methods
0.000
description
20
230000037431
insertion
Effects
0.000
description
20
238000012986
modification
Methods
0.000
description
19
230000004048
modification
Effects
0.000
description
19
230000001788
irregular
Effects
0.000
description
18
238000013500
data storage
Methods
0.000
description
16
230000005540
biological transmission
Effects
0.000
description
15
238000009987
spinning
Methods
0.000
description
15
YAFQFNOUYXZVPZ-UHFFFAOYSA-N
liproxstatin-1
Chemical compound
ClC1=CC=CC(CNC=2C3(CCNCC3)NC3=CC=CC=C3N=2)=C1
YAFQFNOUYXZVPZ-UHFFFAOYSA-N
0.000
description
14
101100468275
Caenorhabditis elegans rep-1 gene
Proteins
0.000
description
13
239000002243
precursor
Substances
0.000
description
12
230000002829
reductive effect
Effects
0.000
description
12
KRQUFUKTQHISJB-YYADALCUSA-N
2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one
Chemical compound
CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1
KRQUFUKTQHISJB-YYADALCUSA-N
0.000
description
11
238000004519
manufacturing process
Methods
0.000
description
10
230000002093
peripheral effect
Effects
0.000
description
10
230000008901
benefit
Effects
0.000
description
8
230000001133
acceleration
Effects
0.000
description
7
241000167854
Bourreria succulenta
Species
0.000
description
6
235000019693
cherries
Nutrition
0.000
description
6
101000726148
Homo sapiens Protein crumbs homolog 1
Proteins
0.000
description
5
101000610557
Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp31
Proteins
0.000
description
5
102100027331
Protein crumbs homolog 1
Human genes
0.000
description
5
101000825534
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 40S ribosomal protein S2
Proteins
0.000
description
5
101001109965
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L7-A
Proteins
0.000
description
5
101001109960
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L7-B
Proteins
0.000
description
5
102100040118
U4/U6 small nuclear ribonucleoprotein Prp31
Human genes
0.000
description
5
238000013461
design
Methods
0.000
description
5
241000219109
Citrullus
Species
0.000
description
4
235000012828
Citrullus lanatus var citroides
Nutrition
0.000
description
4
238000004364
calculation method
Methods
0.000
description
4
239000000284
extract
Substances
0.000
description
4
NJPPVKZQTLUDBO-UHFFFAOYSA-N
novaluron
Chemical compound
C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F
NJPPVKZQTLUDBO-UHFFFAOYSA-N
0.000
description
4
238000009877
rendering
Methods
0.000
description
4
101001028804
Homo sapiens Protein eyes shut homolog
Proteins
0.000
description
3
102100037166
Protein eyes shut homolog
Human genes
0.000
description
3
101000643078
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 40S ribosomal protein S9-A
Proteins
0.000
description
3
101000729607
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 40S ribosomal protein S9-B
Proteins
0.000
description
3
101000679735
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L16-A
Proteins
0.000
description
3
230000009471
action
Effects
0.000
description
3
230000002730
additional effect
Effects
0.000
description
3
238000004891
communication
Methods
0.000
description
3
230000008034
disappearance
Effects
0.000
description
3
239000006196
drop
Substances
0.000
description
3
239000000463
material
Substances
0.000
description
3
238000013508
migration
Methods
0.000
description
3
230000005012
migration
Effects
0.000
description
3
230000001681
protective effect
Effects
0.000
description
3
230000002441
reversible effect
Effects
0.000
description
3
238000005070
sampling
Methods
0.000
description
3
102100037460
E3 ubiquitin-protein ligase Topors
Human genes
0.000
description
2
101000662670
Homo sapiens E3 ubiquitin-protein ligase Topors
Proteins
0.000
description
2
101001105683
Homo sapiens Pre-mRNA-processing-splicing factor 8
Proteins
0.000
description
2
101000875616
Homo sapiens Protein FAM161A
Proteins
0.000
description
2
101000610640
Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp3
Proteins
0.000
description
2
101100238610
Mus musculus Msh3 gene
Proteins
0.000
description
2
102100021231
Pre-mRNA-processing-splicing factor 8
Human genes
0.000
description
2
102100036002
Protein FAM161A
Human genes
0.000
description
2
101000862778
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 40S ribosomal protein S3
Proteins
0.000
description
2
101001105592
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L18-A
Proteins
0.000
description
2
101001105589
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L18-B
Proteins
0.000
description
2
101001110823
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-A
Proteins
0.000
description
2
101000712176
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-B
Proteins
0.000
description
2
101100412093
Schizosaccharomyces pombe (strain 972 / ATCC 24843) rec16 gene
Proteins
0.000
description
2
102100040374
U4/U6 small nuclear ribonucleoprotein Prp3
Human genes
0.000
description
2
230000002547
anomalous effect
Effects
0.000
description
2
238000012937
correction
Methods
0.000
description
2
238000007599
discharging
Methods
0.000
description
2
230000009467
reduction
Effects
0.000
description
2
108010071065
ribosomal protein 29
Proteins
0.000
description
2
230000001960
triggered effect
Effects
0.000
description
2
101000971351
Homo sapiens KRR1 small subunit processome component homolog
Proteins
0.000
description
1
101000979001
Homo sapiens Methionine aminopeptidase 2
Proteins
0.000
description
1
101000969087
Homo sapiens Microtubule-associated protein 2
Proteins
0.000
description
1
102100021559
KRR1 small subunit processome component homolog
Human genes
0.000
description
1
102100023174
Methionine aminopeptidase 2
Human genes
0.000
description
1
244000208734
Pisonia aculeata
Species
0.000
description
1
230000005856
abnormality
Effects
0.000
description
1
NIXOWILDQLNWCW-UHFFFAOYSA-N
acrylic acid group
Chemical group
C(C=C)(=O)O
NIXOWILDQLNWCW-UHFFFAOYSA-N
0.000
description
1
230000003247
decreasing effect
Effects
0.000
description
1
230000003111
delayed effect
Effects
0.000
description
1
230000000881
depressing effect
Effects
0.000
description
1
238000011161
development
Methods
0.000
description
1
238000005516
engineering process
Methods
0.000
description
1
238000011156
evaluation
Methods
0.000
description
1
239000003889
eye drop
Substances
0.000
description
1
230000008676
import
Effects
0.000
description
1
238000007562
laser obscuration time method
Methods
0.000
description
1
238000007726
management method
Methods
0.000
description
1
239000000203
mixture
Substances
0.000
description
1
235000019837
monoammonium phosphate
Nutrition
0.000
description
1
230000003287
optical effect
Effects
0.000
description
1
230000000717
retained effect
Effects
0.000
description
1
238000004904
shortening
Methods
0.000
description
1
239000000725
suspension
Substances
0.000
description
1